Analysis of pathology of locomotive disorder and application of synovial mesenchymal stem cells for regenerative medicine

Analysis of pathology of locomotive disorder and application of synovial mesenchymal stem cells for regenerative medicine - Study of synovial mesenchymal stem cells and its application for regenerative medicine

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033162

Enrollment

Registered

2018-06-29

Start date

2018-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locomotive disorder

Interventions

Serum is extracted from volunteer&#39

s blood, and synovial mesenchymal stem cells are cultured by using it.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy adult volunteers with no remarkable medical record and afford to undergo blood sampling as much as 300ml.

Exclusion criteria

Exclusion criteria: Anemic patients

Design outcomes

Primary

Measure	Time frame
Proliferative property of synovial mesenchymal stem cells under volunteers' serum.	—

Countries

Japan

Contacts

Public ContactOffice administrator Office administrator

Tokyo Medical and Dental University Center of Stem Cell and Regenerative Medicine

saisei01.arm@tmd.ac.jp0358034017

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026